Director, Global Access Strategy & Pricing, Oncology Pipeline & BD

Role Summary

The Director Global Access Strategy & Pricing (GASP), Oncology Pipeline & BD will develop market access and pricing strategies for our early clinical and business development opportunities (pre-POC) across priority tumor areas for the Pfizer. Reporting to the Senior Director, Global Access Strategy & Pricing within GAV’s (Global Access and Value) Oncology Pipeline & BD Team, and in collaboration with the cross-functional asset development team, this colleague will: conduct/design and synthesize global payer insights to provide early access and pricing recommendations, propose insights for clinical trial design and investment priorities for the early pipeline, including business development, and oversee the development of financial models to evaluate the impact of lifecycle indications.

Responsibilities

• Provide payer insights to understand/meet the needs of all types of payers in key Pfizer markets and develop an overarching Access Strategy
• Represent the ‘Voice of the Payer’ at cross-functional team and governance bodies for pre-POC priority assets
• Deliver clear recommendations relating to payer strategy, pricing and reimbursement needs, evidence generation, data collection and value proposition via the Integrated Value & Access Strategy (IVAS).
• Achieving the above will require the formation of leadership and/or participation in virtual cross functional Access Matric Teams (AMT). When necessary, convene and coordinate taskforce deployments related to specific asset threats and opportunities.

Responsibilities (continued)

• Generate & synthesize payer insights
  • Lead horizon scanning and in-depth understanding of payer regulations, needs of all types of payers (e.g. HTA agencies, institutions and patients) in key Pfizer markets.
  • Create and maintain expertise in payer regulation and priorities across major countries / archetypes in the region:
    • Assessment and communication of external access trends to anticipate potential challenges and opportunities for pipeline & inline portfolio.
    • Gather and synthesize feedback for development programs with health technology assessment agencies, payers, and relevant patient associations within assigned region
    • Collaborate with Commercial Strategy, Clinical and Medical teams to optimize clinical trial designs which incorporate payer requirements for pricing and reimbursement.
    • Provide price and market access input on early clinical trials and generate access recommendations to key business decision points.
    • Anticipate and navigate key external policy changes and trends (e.g. IRA, EU HTA) to ensure future-proofing of our early access strategies

Qualifications

• Required: Bachelor’s Degree minimum required
• Required: 8 years’ experience minimum required, preferably in healthcare environment, preferably pharmaceutical industry or related consulting services, sufficient to have developed a deep understanding of the global payer and market access environment
• Required: Experience in developing and executing Pricing & Market Access strategies and deliverables on key ex-US market such as Germany, France, UK, Italy and/or Spain.
• Required: Knowledge and understanding of drug development process.
• Required: Pharmaceutical business leadership, including experience in strategy development and interaction with customers.
• Preferred: Advanced degree in a healthcare, business or economic field preferred (PhD, PharmD, MS, MPH, MBA)
• Preferred: Familiarity with strategic and operating planning processes
• Preferred: Knowledge and understanding of health economics and associated skills